Document is current
Any future updates will be listed below
-
Authors
Marx, Gabriella https://orcid.org/0000-0001-6807-9518
Mallon, Tina https://orcid.org/0000-0001-5849-6377
Stanze, Henrikje https://orcid.org/0000-0002-3563-069X
Zimansky, Manuel https://orcid.org/0000-0002-7764-9292
Schneider, Nils https://orcid.org/0000-0002-7242-8298
Nauck, Friedemann https://orcid.org/0000-0001-7592-1654
Scherer, Martin https://orcid.org/0000-0003-3448-9679
Pohontsch, Nadine https://orcid.org/0000-0002-0966-4087
-
Funding
Funding for this research was provided by:
This work was supported by the Federal Joint Committee (01VSF18024, 01VSF18024, 01VSF18024, 01VSF18024, 01VSF18024, 01VSF18024, 01VSF18024, 01VSF18024)
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 4 July 2024
Accepted: 11 February 2025
First Online: 22 February 2025
Declarations
:
: The Ethics Committee of the Medical Association Hamburg, Germany (no. PV7090) approved the KOPAL study. The need to obtain informed consent for participants in step 1 (preparation) was waived by the Ethics Committee as no patient related data were generated. The KOPAL trial was carried out in accordance with the Declaration of Helsinki. All authors confirm all patient/personal identifiers have been removed or disguised so the patient/person(s) described are not identifiable and cannot be identified through the details of the story.
: Not applicable.
: NP is an editorial board member of BMC primary care.
